Related Experiment Video
Updated: May 9, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Myeloperoxidase G463A polymorphism and lung cancer risk in Asians: a pooled analysis
Yi-yong Zhou1, Shao-ming Zhang, Zhi-gang Cai
1Thoracic Tumor Center, People's Liberation Army 455 Hospital, 338 West Huaihai Road, Changning District, Shanghai, 200052, China.
Abstract:
Myeloperoxidase (MPO) is an endogenous oxidant enzyme and can generate reactive oxygen species. The MPO G463A polymorphism influences MPO transcription levels and has been proposed to be associated with risk of lung cancer. To assess the effect of MPO G463A polymorphism on lung cancer risk in Asians, a pooled analysis of published case-control studies was performed. PubMed, Embase, China Biomedical Literature, and Wanfang Medicine databases were searched for eligible studies. The strength of the association between MPO G463A polymorphism and lung cancer risk was measured by odds ratio (OR) with 95 % confidence interval (95% CI). Finally, eight studies with a total of 1,679 lung cancer cases and 1,876 non-cancer controls were included. Overall, MPO G463A polymorphism was associated with decreased risk of lung cancer risk in Asians under two genetic models (OR AA vs. GG = 0.58, 95% CI 0.36-0.96, P = 0.033; OR AA vs. GG+AG = 0.60, 95% CI 0.37-0.98, P = 0.040). There was no obvious risk of publication bias in this meta-analysis. In conclusion, the pooled analysis suggests that MPO G463A polymorphism is associated with decreased risk of lung cancer risk in Asians.
Insights
The myeloperoxidase (MPO) G463A polymorphism is linked to a reduced risk of lung cancer in Asian populations. This genetic variation may offer protective effects against developing lung cancer.
Area of Science:
- Genetics
- Oncology
- Biochemistry
Background:
- Myeloperoxidase (MPO) is an enzyme that produces reactive oxygen species.
- The MPO G463A polymorphism affects MPO gene transcription and may influence lung cancer risk.
Purpose of the Study:
- To evaluate the association between the MPO G463A polymorphism and lung cancer risk in Asian individuals.
- To conduct a pooled analysis of existing case-control studies.
Main Methods:
- Searched PubMed, Embase, China Biomedical Literature, and Wanfang Medicine databases.
- Included eight case-control studies with 1,679 lung cancer cases and 1,876 controls.
- Calculated odds ratios (OR) with 95% confidence intervals (CI) to measure the association.
Main Results:
- The MPO G463A polymorphism showed a significant association with decreased lung cancer risk in Asians.
- Results were consistent across two genetic models: AA vs. GG (OR=0.58, 95% CI 0.36-0.96) and AA vs. GG+AG (OR=0.60, 95% CI 0.37-0.98).
- No significant publication bias was detected in the meta-analysis.
Conclusions:
- The MPO G463A polymorphism appears to be associated with a reduced risk of lung cancer in Asian populations.
- This finding suggests a potential protective role of this genetic variant against lung cancer development in this demographic.
